jl Mehta

Distingusihed Professor

University of Arkansas System

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. JL Mehta is a Distinguished Professor at the University of Arkansas System, USA. His research focuses on cardiovascular diseases, particularly in areas such as cholesterol transport dynamics, ischemia-reperfusion injury, and the role of protein and exosomes in cardiac health. He has contributed significantly to understanding heart failure prevention and management through recent studies exploring the applications of innovative therapies and lifestyle factors.

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

ITALY

View details

Gaurav Dhar

Section Chief Structural Cardiology, Program Director Structural Heart Disease. Professor of Medicine

Rush University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

jl Mehta

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Remodelling-derived pre-β1 and remnant HDL particles: a snapshot of reverse cholesterol transport dynamics and efficiency

Molecular Insights into Ischemia–Reperfusion Injury in Coronary Artery Disease: Mechanisms and Therapeutic Implications: A Comprehensive Review

‘Exerkines’: A Comprehensive Term for the Factors Produced in Response to Exercise

Direct Impact of PCSK9 on SMC Senescence and Apoptosis: A New Focus in Cardiovascular Diseases

Percutaneous Patent Foramen Ovale Closure: Stroke and Beyond

Applications of ChatGPT in Heart Failure Prevention, Diagnosis, Management, and Research: A Narrative Review

Proteomic analysis of transcription factors involved in the alteration of ischemic mouse heart as modulated by MSC exosomes

NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases

Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study

Age Modifies Intracranial and Gastrointestinal Bleeding Risk from P2Y12 Inhibitors in Patients Receiving Dialysis

Vegetarianism, microbiota, and cardiovascular health: looking back, and forward

Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis

Mesenchymal stem cell treatment for hyperactive immune response in patients with COVID-19

Syndemic: A Synergistic Anthropological Approach to the COVID-19 Pandemic

PEGylated Gold Nanoparticle Toxicity in Cardiomyocytes: Assessment of Size, Concentration, and Time Dependency

The structural basis of effective LOX-1 inhibition

Collaborators (7)

Jerry Ware

Terry Harville

Milind Phadnis

S Susan Hedayati

Jin-Woo Kim

Cesare de Gregorio

Gaurav Dhar

Make your next move.